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Tuesday, March 3, 2009 499adirection. This data suggests that Vin contributes to the passive mechanical
properties of the myocardium, and disrupting the mechanical linkage between
the cytoskeleton and the cell membrane reduces the overall stiffness of the
myocardium.
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We have developed a polyclonal antibody specific to skeletal muscle actin
(ACTA1) in the presence of cardiac actin (ACTC) and have used it to quantify
the skeletal actin content of human and mouse cardiac muscle. Heart muscle
myofibrils were separated by SDS-PAGE and Western blotted. The membrane
was stained first with MemCode total protein stain and then probed in with the
anti-skeletal muscle actin antibody, visualised by ECL. The ECL band signal
was normalised to MemCode-stained actin band. Skeletal muscle myofibrils
were used as a 100% skeletal actin standard. For the negative control we used
myofibrils from skeletal muscle of a skeletal actin knockout mouse crossed
with a transgenic mouse over-expressing cardiac actin in skeletal muscle. There
was no detectable signal from the skeletal actin antibody in the pure cardiac actin
control.
Human non-failing donor heart muscle contained 2152% skeletal actin
(n¼9). This is comparable to previous estimates using N-terminal sequencing
or Mass spectroscopy. In both end-stage failing heart muscle and in myec-
tomy samples from HCM muscle the skeletal actin content was much higher
(5855% in both cases, n¼12, 11). The increase in skeletal actin content of
myopathic muscle was highly significant (p< 0.001). Mouse heart muscle
(C57BL/6 strain) contains 2653% skeletal actin (n¼7). This is similar to
human heart. ACTC DCM mutation E361G expressed at 50% in mouse heart
has 1653% (n¼8) skeletal actin but ACTC HCM mutation E99K expressed
at 50% is not significantly different from NTG 2452% (n¼5). We conclude
that in human heart, acquired heart failure or failure secondary to HCM is
associated with an increased content of skeletal muscle actin. In contrast,
in mouse genetic models of HCM and DCM skeletal muscle actin content
may be lower than normal.
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FHC is a primary cardiac muscle disorder that is one of the most common
causes of sudden death in young people. FHC ‘‘hotspot’’ mutations at residue
92 in cardiac troponin T (cTnT) flank the proposed a-helical TNT1 tail domain
whose flexibility has been suggested to be important in normal protein-protein
interactions within the thin filament. Through Molecular Dynamics (MD) sim-
ulations, we showed that FHC mutations Arg92Leu, Arg92Trp, and Arg92Gln
cause local a-helical structural changes and increased flexibility at a critical
hinge region 18 Angstroms distant from the mutation. We have extended this
MD analysis via the use of a self-defined coordinate to measure localized bends
in the helix and found that forces acting on this bending coordinate are lower in
mutants than wildtype. This quantitatively suggests a less restrictive bending
motion in mutants explaining the increased flexibility of the hinge region. To
determine how primary biophysical changes induced by these mutations cause
complex cardiomyopathies we hypothesize that flexibility alterations and
changes in force within compaction-expansion regions in mutational segments
lead to electrostatic perturbations, possibly interfering with cTnT-TM complex
formation and thin filament function. In vitro motility assays with wildtype
cTnT and hotspot FHC-cTnT mutants are in progress to directly correlate pre-
dicted alterations in electrostatic properties with resultant functional changes.
Moreover, contractile and Ca2þ transient measurements on isolated myocytes
address downstream myocellular responses to the mutation’s primary perturba-
tion on structure and function. Data showed normal percent shortening in Ar-
g92Leu myocytes while Arg92Trp percent shortening was significantly im-
paired compared to Non-Tg (4.740 þ 1.165 vs. 6.971 þ 2.098, p<0.001).
Completion of these studies will directly address the links between thin fila-
ment structure/function, downstream myocellular responses, and resultant dis-
tinct cardiovascular phenotypes.2573-Pos Board B543
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Familial Hypertrophic Cardiomyopathy (FHC) is a primary disease of the
cardiac sarcomere. Many disease-causing mutations in the thin filament pro-
tein cTnT are found within the TNT1 region. Residues 160-163 represent
a mutational hotspot within a highly charged region (158-RREEEENRR-
166). In this region, this highly alpha helical domain may unwind to create
a flexible hinge that is necessary for function, the structure and dynamics
of which may be affected by FHC mutations. We are investigating the
structure and function of this region using in vitro motility (IVM) assays
and SDSL-EPR. The purpose of our IVM experiments is two-fold: to func-
tionally analyze our spin labeled proteins and to gain insight into the func-
tion of TNT1 in the presence of cysteine substitutions and FHC mutations.
Preliminary IVM data shows a progressive increase in the severity of the
functional effects of cysteine substitution and spin labeling across the puta-
tive hinge region (153<168<172), suggesting that this region is dynami-
cally important and may be making critical interactions with other compo-
nents of the sarcomere. Preliminary CW-EPR spectra show an increase in
isotropic rotational rate at residue 153 (upstream of the putative hinge re-
gion) between cTnT alone and in the troponin ternary complex, suggesting
that there is a decrease in alpha helical character at this residue in the ter-
nary complex. Introduction of D160E further increases the isotropic rota-
tional rate, suggesting an increase in flexibility due to backbone changes
induced by the mutation. To further investigate structural and functional
changes caused by FHC mutations within the putative hinge region, we
will continue to expand our IVM functional analyses with additional cyste-
ine substitutions, as well as FHC mutations at residues 160 and 163. Dou-
ble label SDSL-EPR are currently underway that will provide secondary
and tertiary structural information.
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Previous studies have shown that MLCK-phosphorylation of the ventricular
regulatory light chain (RLC) increases myofilament Ca2þ sensitivity, maximal
level of force and rate of tension development thereby enhancing the systolic
function of the heart. We have investigated the effect of FHC (familial hyper-
trophic cardiomyopathy) mutations in the myosin RLC on its phosphorylation
measured in rapidly frozen ventricular samples from transgenic (Tg) mice. We
observe that the Aspartate to Valine substitution in Tg-D166V mice and Ar-
ginine to Glutamine in Tg-R58Q mice result in a decreased phosphorylation
of RLC detected in left ventricular samples from Tg-mutant compared to
Tg-WT mice expressing the human ventricular RLC. The level of RLC phos-
phorylation was determined by Western blotting utilizing human specific
phospho-RLC antibodies (gift from Dr. N. Epstein, NIH). Our data from
skinned Tg-D166V and Tg-R58Q papillary muscle fibers show that both
RLC mutations lead to a decreased maximal level of force and to slower ki-
netics of force generating myosin cross-bridges compared to WT fibers. Stud-
ies in intact papillary muscle fibers show prolonged force transients for both
D166V and R58Q mutants. In addition, the hearts of aging mutant mice dem-
onstrate histopathological changes and frequent occurrences of fibrotic le-
sions. Clinical studies revealed that both D166V and R58Q mutations are as-
sociated with severe FHC phenotypes with multiple cases of sudden cardiac
death. Our results suggest that phosphorylation of RLC plays an important
role in regulating cardiac function and its deficit may contribute to malignant
FHC phenotypes. Reduced RLC phosphorylation observed in the D166V and
R58Q hearts correlates with our cellular findings and could be responsible for
delayed force transients, slower cross-bridge kinetics and decreased force ob-
served in Tg-D166V and Tg-R58Q papillary muscle fibers. Supported by
NIH- HL071778 (D.S-C.).
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The mutation Gly99lys (E99K) in the cardiac actin (ACTC) gene was reported
to cause Hypertrophic Cardiomyopathy in extensive clinical studies. Trans-
genic (TG) mice expressing 50% E99K mutant cardiac actin in their hearts
were generated and studied. The mice show high mortality between 28 and
45 days old (70% females, 34% males).
Thin filaments reconstituted with purified mouse f-actin from the survivors and
human heart tropomyosin and troponin were studied by in vitro motility assay.
The E99K thin filaments were 2.55 0.6 times more Ca2þ sensitive than NTG
thin filaments (p ¼ 0.05). E99K actin thin filaments also exhibited a reduced
response to troponin dephosphorylation (EC50 E99K/E99KdP ¼ 1.1 5 0.1
compared with 3.05 0.3 for NTG /NTGdP).
7 month-old E99K TG mice (n¼9) and their NTG littermates (n¼7) were
studied using in vivo cine MRI. Abnormal cardiac morphology and signif-
icantly lower ejection fractions (56.5 vs. 65.2%) and reduced stroke vol-
umes (26.0 vs. 42.3 ml) were observed in TG mice. Peak LV ejection
rates were also reduced (188 5 41 vs. 252 5 49 ml/min). LV mass
was similar between groups, but septal wall thickness was increased (1.5
vs. 1.0 mm).
Left ventricular function of 9 month-old female E99K NTG (n¼4) and TG
(n¼5) mice were studied with an in vivo conductance catheter. In TGmice ejec-
tion fraction was 20.2% less, end-diastolic pressure was 39.6% higher and
relaxation rate was 50.0% slower.
We conclude that the basic effect of E99K mutation is increased Ca2þ-sensitiv-
ity and blunted response to troponin dephosphorylation and this leads to the
high rate of sudden death at early ages, alterations to cardiac function and hy-
pertrophy as observed in patients with hypertrophic cardiomyopathy.
Supported by a grant from the British Heart Foundation
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At the myofilament level, increases in cardiac output in response to in-
creased sympathetic tone is achieved via protein kinase A (PKA)-mediated
phosphorylation of cardiac myosin binding protein C (cMyBP-C) and car-
diac troponin I (cTnI). However, despite the physiological importance of
b-adrenergic stimulation in maintaining cardiac performance, the respective
roles of cMyBP-C and cTnI phosphorylations in the myofibrillar force re-
sponse of working myocardium are not completely understood. Using trans-
genic mouse lines either (1) expressing mutant non-phosphorylatable cTnI
(cTnIala5) or (2) expressing cTnIala5 on a cMyBP-C null background
(cMyBP-C-/-/cTnIala5), we assessed the calcium sensitivity of force
(pCa50) and the rate of force redevelopment (ktr) in skinned myocardial
preparations following treatment with PKA and/or reconstitution with puri-
fied recombinant cMyBP-C. Before mechanical measurements, all prepara-
tions were treated with 2,3-butanedione monoxime (BDM) to reduce regu-
latory light chain (RLC) phosphorylation to near zero. In cTnIala5
myocardium, PKA phosphorylation of cMyBP-C resulted in a decrease in
pCa50 and an increase in ktr. However, no changes in either variable
were observed in cMyBP-C-/-/cTnIala5 myocardium in response to PKA
treatment. Following reconstitution of cMyBP-C-/-/cTnIala5 myocardium
with cMyBP-C, ktr decreased to the values observed in cTnIala5 myocar-
dium, demonstrating that incorporation of cMyBP-C slowed the rates of
cross-bridge attachment and transitions to strongly bound, force generating
states. Subsequent treatment of reconstituted cMyBP-C-/-/cTnIala5 myocar-
dium with PKA produced a rightward shift in pCa50 and an increase in
ktr. Together, these results suggest that in the absence of cTnI phosphory-
lation (and RLC phosphorylation), PKA phosphorylation of cMyBP-C de-
creases calcium sensitivity of force and speeds cross-bridge cycling kinetics
in murine myocardium.
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Cardiac myosin binding protein-C is a regulatory protein associated with sarco-
mere A-bands that modulates actomyosin interactions in a phosphorylation de-pendent manner. The MyBP-C motif, a highly conserved sequence in the N-ter-
minus of cMyBP-C, contains three to five protein kinase A (PKA)
phosphorylation sites, depending on species. In the human isoform, three PKA
sites have been identified (S275, S284, and S304). Three homologous sites exist
in the murine isoform (S273, S282, and S302) along with a potential fourth site,
S307, which is not present in human cMyBP-C. In this study, we investigated the
effects of PKA phosphorylation of murine cMyBP-C by treating a recombinant
protein, C1C2 (which contains the C1, motif, and C2 domains), with PKA and
assessing phosphorylation levels using IEF gels, ProQ Diamond staining, and
mass spectrometry. The wild-type C1C2 has a pI of ~8 and PKA treatment
(C1C2P) shifted the pI to ~5-6 as determined by 1-D IEF gels. A mutant
C1C2 (3S/D), containing aspartic acid for serine substitutions at S273D,
S282D, and S302D, was still phosphorylated upon treatment with PKA as in-
dicated by increased ProQ Diamond staining. However, a mutant 4S/D C1C2
(containing the additional mutation S307D) showed a pI near that of C1C2P
and was not further phosphorylated by PKA. Mass spectrometry and MASCOT
analysis of C1C2P confirmed that S307 was phosphorylated by PKA. These re-
sults suggest that murine S307 can be phosphorylated in vitro. Further studies
are needed to investigate the phosphorylation state of murine cMyBP-C in vivo.
Supported by NIH HL080367 to SPH and a NSF Graduate Research Fellowship
to JFS.
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Myosin Binding Protein C (MyBP-C) is a sarcomeric protein that has both
structural and regulatory roles in striated muscle contraction. Cardiac (c) iso-
forms of MyBP-C can be phosphorylated by protein kinase A (PKA) at three
to five sites within a unique regulatory region referred to as the MyBP-C
motif. We have previously shown, using permeabilized rat trabeculae, that
the recombinant protein C1C2, which contains the motif, significantly in-
creased Ca2þ sensitivity of force and increased rates of tension redevelop-
ment (ktr) at submaximal [Ca2þ]. To investigate whether these effects are
modulated by phosphorylation of the motif, we used the catalytic subunit
of PKA to phosphorylate C1C2. In addition, we used site directed mutagen-
esis to mutate three key serine residues (Ser273, 282, 302) to aspartic acids
to mimic phosphorylation at these sites. Results demonstrated that either
10uM phosphorylated C1C2 (C1C2P) or 10uM phospho-mimic C1C2
(C1C23S/D) increased Ca2þ sensitivity of force and increased rates of ten-
sion redevelopment (ktr) at submaximal [Ca2þ]. However, the phospho-
mimic C1C23S/D was more effective than C1C2P in producing these effects.
Together these results indicate that the 3 Ser to Asp phospho-mimic does not
fully mimic effects of PKA phosphorylation of C1C2 and that the functional
effects of C1C2 in permeabilized cardiac trabeculae are mediated at least in
part through phosphorylation-independent mechanisms. Supported by NIH
HL080367.
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Post-translational modification of troponin (Tn) and other myofilament proteins
by protein kinase C (PKC) isozymes plays a prominent role in regulating myo-
cardial contraction. Conventionally, phosphorylation of conserved serine and
threonine residues in the c-terminus activates PKCdelta, a novel calcium inde-
pendent isozyme. Several recent investigations including our work (Sumandea
et al. J Biol Chem. 2008;283(33):22680-9) have led to the probability of alter-
native activation of PKCdelta by tyrosine residue phosphorylation through a re-
dox-sensitive mechanism. Previous work determined PKCdelta phosphoryla-
tion of adult, cardiac rat myocytes in vitro reduces skinned myocyte tension
generation at sub-maximum with no change at maximum calcium concentra-
tions. Conversely, tyrosine phosphorylated PKCdelta reduces the maximal
Ca-activated tension with no decrease in submaximal tension production. Bio-
chemical data indicated a shift in TnI residue targeting with tyrosine phosphor-
ylated PKCdelta from exclusive phosphorylation of S23/24, to include T144.
To test the hypothesis that kinase targeting to TnI-T144 was sufficient to blunt
effects of conventional PKCdelta targeting to TnI-S23/24, myofibrillar function
was assessed following exchange of TnI with pseudo-phosphorylated residues.
Pseudo-phosphorylation at residues S23/24 decreased Ca-sensitivity of force
production and increased tension cost. Pseudo-phosphorylation at TnI-144
had minimal affect on mechanical parameters. However, the combination of
pseudo-phosphorylations at residues S23/24 and T144 did not successfully
blunt desensitization. Further biochemical assessments have determined
